May 15 - 17, 2017
Keynote Speaker: Vijay K. Kuchroo (Harvard Institutes of Medicine)
Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.
Thursday, May 25, 2017 | 9:00 AM - 5:00 PM
Keynote Speaker: Craig Thompson (Memorial Sloan Kettering Cancer Center)
This symposium will highlight insights into tumor metabolism from leaders in the field and explore how this information is being used to design safe and effective, metabolism-targeted therapies.
June 21 - 22, 2017
Experience a public-facing dialogue exploring the nuanced ethical and scientific rationale behind randomized controlled clinical trials, accelerated alternatives, and the implications of these discussions on drug approval and patient interests.
Thursday, November 2, 2017 | 9:00 AM - 5:00 PM
Speakers: Marcia Haigis (Harvard Medical School), Vamsi Mootha (Harvard Medical School), Andrew Dillin (UC Berkeley), Adam Hughes (University of Utah School of Medicine), Jahar Bhattacharya (Columbia University Irving Medical Center), Jodi Nunnari (University of California, Davis), Navdeep S. Chandel (Northwestern University), J. Wade Harper (Harvard Medical School), and David J. Glass (Novartis Institutes for Biomedical Research)
This symposium will bring together cross-disciplinary researchers to explore mitochondrial biology, the role played by mitochondria in disease, and their potential as a therapeutic target.
Tuesday, April 11, 2017 | 9:00 AM - 5:00 PM
Speakers: Brian Kaspar (AveXis Inc.), R. Jude Samulski (Bamboo Therapeutics), Barry Byrne (University of Florida Powell Gene Therapy Center), Maria Escolar (University of Pittsburgh), Jakub Tolar (University of Minnesota), Kevin Flanigan (Nationwide Children's Hospital), Katherine A. High (Spark Therapeutics), and Steven J. Gray (University of North Carolina at Chapel Hill)
Gene therapy has been proposed as a promising therapeutic strategy for monogenic disorders. This symposium will explore recent advances in the field, and identify ongoing obstacles on the path to wider use of this approach.
Monday, March 13, 2017 | 9:00 AM - 4:45 PM
Speakers: Michael G. Agadjanyan (The Institute for Molecular Medicine), Bernardino Ghetti (Indiana University School of Medicine), Khalid Iqbal (New York State Institute for Basic Research in Developmental Disabilities), Viktoriya Morozova (College of Staten Island, The City University of New York), Einar M. Sigurdsson (New York University School of Medicine), Qian Wu (New York University School of Medicine), Emanuele Sher (Lilly UK), and Henrik Zetterberg (University of Gothenburg, Sweden)
This event will cover the translational potential of immunotherapy for tauopathies, reviewing the pre-clinical and clinical development of several tau immunotherapy programs that exemplify this emerging therapeutic approach.
February 27 - 28, 2017
Keynote Speaker: Padmanee Sharma (The University of Texas MD Anderson Cancer Center)
Discover the latest on immunotherapeutic strategies that are currently being employed to treat some of the most devastating forms of cancer from leading experts in immunotherapy.
This event is sold out.
Saturday, January 28, 2017 | 11:00 AM - 4:00 PM
This event gives professionals from across the biopharmaceutical space — from scientists and industry executives, through healthcare providers and insurers to investors — a visceral understanding of how biopharma innovation dynamics are evolving, mimicking decision-making under pressure in a complex and changing environment.
Edited by Ann NY Acad Sci
Scholarly papers exploring healthy nutritional status among adolescents and young women
Featuring: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Universite Catholique de Louvain, LDRI), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), Marion Soto (Joslin Diabetes Center, Harvard Medical School), and Dan Winer (University of Toronto)
The microbiome is emerging as an important regulator of health and disease well beyond the digestive tract. This eBriefing surveys highlights from recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.
Edited by Rexford Ahima
(Johns Hopkins University School of Medicine)
Scholarly reviews of current topics in diabetes and obesity
Organizers: Melanie Brickman Borchard (The New York Academy of Sciences), Alison Carley (The New York Academy of Sciences), Daan J.A. Crommelin (Utrecht University), Wenlei Jiang (US Food and Drug Administration), Scott McNeil (Nanotechnology Characterization Laboratory), Vinod Shah (Non Biological Complex Drugs Working Group), and Jon de Vlieger (Lygature)
This eBriefing looks at approaches for complex drug development and regulation, outstanding challenges in the assessment of complex drug equivalence, consequences for product interchangeability, and comparisons of biological and non-biological complex drug families.